Sanofi Chief Urges S. Korea Drug Researchers To Focus On Biologics IT
This article was originally published in PharmAsia News
Executive Summary
Sanofi Group CEO Christopher Viehbacher says South Korea's work force has the talent required by a competitive pharmaceutical industry increasingly dependent on digital technologies.